Medeloop, a Palo Alto, CA-based healthtech startup, raised $8M in Seed funding.
The round was led by General Catalyst with participation from Maven Ventures, the Ovo Fund, NV investments (led by Vivi Nivo), Ken Frazier (former Chairman and CEO of Merck), Dr. Linda Grais (former biotech founder and CEO), and others. Elena Viboch, Partner at General Catalyst, will join the Medeloop board.
The company intends to use the funds to launch an end-to-end solution for early stage clinical research.
Led by Founders, CEO Dr. Rene Caissie, CTO Raghav Samavedem, CSO Dr. Josh Walonoski, and COO Andy Yakulis, Medeloop provides an AI-driven platform that integrates, harmonizes, and analyzes health data using advanced AI tools that have the potential to expedite the clinical research process. These insights can facilitate breakthroughs in research.
By employing AI techniques, the platform streamlines researcher discovery by simplifying grant applications, data collection, harmonization, biomarker and trend identification, and manuscript submissions.
FinSMEs
21/09/2023